Skip Navigation


European Heart Journal Advance Access originally published online on July 28, 2006
European Heart Journal 2006 27(18):2152-2153; doi:10.1093/eurheartj/ehl171
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/18/2152    most recent
ehl171v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Panhuyzen-Goedkoop, N. M.
Right arrow Articles by Verheugt, F. W.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panhuyzen-Goedkoop, N. M.
Right arrow Articles by Verheugt, F. W.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Sudden cardiac death due to hypertrophic cardiomyopathy can be reduced by pre-participation cardiovascular screening in young athletes

Nicole M. Panhuyzen-Goedkoop1,2,* and Freek W.A. Verheugt2

1 Sint Maartenskliniek location Sports Medical Centre Papendal, Arnhem, The Netherlands
2 Heart Centre Radboud University Hospital, Nijmegen, The Netherlands

* *Corresponding author. Tel: +31 26 48 34 440; fax: +31 26 36 37 649. E-mail address: nicole.panhuyzen@planet.nl

This editorial refers to ‘Evidence for efficacy of the Italian national pre-participation screening program for identification of hypertrophic cardiomyopathy in competitive athletes’{dagger} by A. Pelliccia et al., on page 2196

The first 10% of the full text of this article appears below.

Sudden death of a young well-trained athlete has a high impact on everyone involved and raises concern in the medical community. It is hardly acceptable that a ‘healthy’ individual dies suddenly during athletic activity. And the question that always arises is whether this athlete could have been identified by pre-participation cardiovascular screening and this sudden cardiac death could have been prevented. The first documented ‘marathon runner’ dying suddenly within an hour after physical exertion while announcing the Greek victory (‘Niké’) over the Persians was Pheidippides in 490 BC. More recently, the death of well-trained athletes has focused interest on pre-participation cardiovascular screening. The European Association for Cardiovascular Prevention and . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes
Antonio Pelliccia, Fernando M. Di Paolo, Domenico Corrado, Cosimo Buccolieri, Filippo M. Quattrini, Cataldo Pisicchio, Antonio Spataro, Alessandro Biffi, Maristella Granata, and Barry J. Maron
EHJ 2006 27: 2196-2200. [Abstract] [Full Text]